On the recordApril 23, 2018
We have discussed the frustration we both share about the anti-competitive tactics used by brand drug companies to deny the sale of samples to generic manufacturers.
Source
congress.govEditor's note · Context
Leahy expresses shared frustration over brand drug companies' tactics against generics.
Share
More from Patrick Leahy
Dec 20, 2022
I am pleased to announce that late last night, I introduced the bipartisan, bicameral, fiscal year 2023 omnibus appropriations bill. This bill invests $772.5 billion in nondefense discretionary programs, including $118.7 billion--a…
Nov 28, 2022
today marks the 1-year anniversary of the election of Xiomara Castro Sarmiento, the first woman to hold the office of President of Honduras. She succeeded Juan Orlando Hernandez who had discredited the office of the Presidency by colluding…
Dec 6, 2022
we have so many things going on in Washington these days, with just about everything from budgetary matters to wrapping up this session of the Congress. I was delighted today to take a step back and, in my role as President pro tempore…
Dec 15, 2022
a continuing resolution to March 10 is short-sighted and wholly unnecessary. It imperils our national security, and it ignores the real pain and consequences of inflation. Without funding from a full-year omnibus appropriations bill, the…
Other voices in this conversation
